Ob/Gyn Medical News about Mifepristone

Your Unread Messages

See All

Tracy Hampton, PhD

Clinical Trial Watch

Palliative Care Benefits Patients with Advanced Cancer

Roberta Buell, MBA
Congress Proposes SGR Fix

Dorothy J. Schirf, MD

Technology Advances

Targeted Melanoma Therapy May Derive From the Deep

Sara Hartley

Cancer Science

The Depressing Thing About Cancer

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The effect of mifepristone on the peripheral blood natural killer cells cytotoxicity and expression of CD94/NKG2A and NKG2D during the implantation phase
Fertility and Sterility, 11/03/09

Chen XY et al. – The data suggest that Mifepristone may be exert its anti–implantation function by increasing NK cytotoxicity. The increasing NK cytotoxicity of mifepristone is not related to CD94/NKG2A and NKG2D. In the secretory phase down–regulated CD94/NKG2A, NKG2D, and NK cytotoxicity may benefit with embryo implantation.

<< Previous
Risk Factors for Complete Molar Pregnancy: A Study in Iran

Next >>
Gene expression during successful implantation in a natural cycle